Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherona Bau

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Gastroenterology|September 19, 2013
Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infectionKali Zhou, Jessica Ferguson, Sherona Bau, et al.
Cureus|January 21, 2025
An Unusual Case of Chylous AscitesThanda Aung, Mia Celestin, Sherona Bau, et al.
The Nurse Practitioner|December 19, 2024
Overview of chronic hepatitis B managementAngela Jun, Sherona Bau, John S Kim, et al.
Journal of Clinical and Translational Hepatology|June 29, 2016
Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United StatesSammy Saab, Melissa Jimenez, Tiffany Fong, et al.
Journal of Clinical Gastroenterology|January 31, 2025
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United StatesBrian P Lam, Jessica Bartholomew, Sherona Bau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2014
Boceprevir in liver transplant recipientsSammy Saab, Vignan Manne, Sherona Bau, et al.
Clinical Transplantation|July 7, 2015
Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysisSammy Saab, Melissa Jimenez, Sherona Bau, et al.
Journal of Clinical and Translational Hepatology|April 6, 2016
Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant UseSammy Saab, Justin Rheem, Melissa Jimenez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Gastroenterology|September 19, 2013
Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infectionKali Zhou, Jessica Ferguson, Sherona Bau, et al.
Cureus|January 21, 2025
An Unusual Case of Chylous AscitesThanda Aung, Mia Celestin, Sherona Bau, et al.
The Nurse Practitioner|December 19, 2024
Overview of chronic hepatitis B managementAngela Jun, Sherona Bau, John S Kim, et al.
Journal of Clinical and Translational Hepatology|June 29, 2016
Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United StatesSammy Saab, Melissa Jimenez, Tiffany Fong, et al.
Journal of Clinical Gastroenterology|January 31, 2025
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United StatesBrian P Lam, Jessica Bartholomew, Sherona Bau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2014
Boceprevir in liver transplant recipientsSammy Saab, Vignan Manne, Sherona Bau, et al.
Clinical Transplantation|July 7, 2015
Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysisSammy Saab, Melissa Jimenez, Sherona Bau, et al.
Journal of Clinical and Translational Hepatology|April 6, 2016
Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant UseSammy Saab, Justin Rheem, Melissa Jimenez, et al.
Pageof 1